Form 4: Core Scientific Director Acquires Shares Through Restricted Stock Unit Grant

Core Scientific director Jeffrey David Booth acquired 20,448 shares through a restricted stock unit grant, which will vest on January 27, 2026.

Summary

• Jeffrey David Booth, a director at Core Scientific, Inc., acquired 20,448 shares of common stock.
• The acquisition was through a restricted stock unit (RSU) grant.
• The RSUs will vest in full on January 27, 2026, provided Mr. Booth continues to serve as a non-employee director.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to director compensation. It is neither particularly positive nor negative, but rather a standard practice.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Risks

• The vesting of the RSUs is contingent on Mr. Booth's continued service as a non-employee director, which introduces a risk of forfeiture if he leaves before the vesting date.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This is a standard SEC filing related to insider transactions and is common for publicly traded companies. It does not indicate any specific industry trend.

Comparison to Industry Standards

• The granting of restricted stock units to directors is a common practice in publicly traded companies as a form of compensation and incentive.
• The vesting period of one year is also a typical timeframe for such grants.
• Similar filings are regularly made by directors and officers of other companies in the technology and cryptocurrency sectors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Core Scientific, Director, Jeffrey David Booth, Restricted Stock Unit, RSU, Share Acquisition, SEC Form 4, Insider Trading